Craig W. Kliethermes, Chief Executive Officer of RLI Corp, filed a Form 4 on November 3, 2026, disclosing a stock option grant and a common stock acquisition via dividend reinvestment dated October 8, 2026, and November 2, 2026, respectively.

Key Highlights

  • Stock option grant: Kliethermes received 15,000 stock options on November 2, 2026, with an exercise price of $67.24, acquired at $0 cost.
  • Vesting schedule: Options vest in 20% increments beginning one year from the grant date, with an expiration date of November 2, 2034.
  • Dividend reinvestment: 1,980 shares of common stock were acquired on October 8, 2026, at $0 price via dividend reinvestment, bringing direct beneficial ownership to 155,970 shares.
  • Split-adjusted figures: The stock option grant price and number of stock options were adjusted to reflect a 2-for-1 stock split on January 15, 2025.
  • Direct ownership: Following the reported transactions, Kliethermes directly holds 155,970 shares of common stock.
  • No derivative holdings remaining: Following the option grant, the filing reports 0 derivative securities beneficially owned after the transaction.

Kliethermes Option Grant and Dividend Reinvestment Details for RLI Corp

According to the Form 4 filed with the SEC on November 3, 2026, Craig W. Kliethermes, Chief Executive Officer of RLI Corp (NYSE:RLI), reported two transactions. The first, dated October 8, 2026, reflects the acquisition of 1,980 shares of common stock at $0 through dividend reinvestment. Following that transaction, the filing shows Kliethermes directly owned 155,970 shares, with the filing noting that ownership reflects dividend reinvestment.

The second transaction, dated November 2, 2026, is a stock option grant under transaction code "A" (acquired). The filing discloses that 15,000 stock options were granted with an exercise price of $67.24 per share and a $0 acquisition cost. The filing states these options are subject to a vesting schedule "wherein 20% of the aggregate number of shares granted may be exercised commencing one year from grant date and each year thereafter in 20% increments." The options expire on November 2, 2034, and are exercisable beginning November 2, 2027. The underlying security is common stock covering 15,000 shares.

The filing further notes that the stock option grant price and number of stock options were "adjusted to reflect 2-for-1 stock split on 01/15/25." The Form 4 was filed by one reporting person and was not flagged as an amendment to a prior filing. The filing was signed by Craig W. Kliethermes on November 3, 2026.

What Was Disclosed

The filing disclosed two transactions by RLI Corp's CEO: an acquisition of 1,980 common shares via dividend reinvestment on October 8, 2026, and a grant of 15,000 stock options at $67.24 on November 2, 2026, vesting in 20% annual increments through 2034.